About this trial
The current guidelines used to manage malnutrition among infants aged below 6 months (u6m) recommend that infants admitted to hospital with malnutrition be supported to reestablish exclusive breastfeeding before discharge. Studies have shown that reestablishing exclusive breastfeeding among infants being treated for acute malnutrition is possible. However, follow-up of the infants after discharge has revealed poor growth raising questions about what happens to infant feeding practices after discharge and whether providing breastfeeding support to mothers after discharge would help improve the recovery and growth of their infants.
Providing a package of home-based care with breastfeeding support to mothers of infants u6m recovering from acute malnutrition has the potential to improve the retention of exclusive breastfeeding and lead to enhanced infant growth and survival. To date, no such post-discharge package of care is available in Kenya or other lower and meddle income countries (LMICs). The aim of this study is to apply participatory, qualitative and quantitative approaches to develop and evaluate the impact of a post-discharge package of care on the growth and development of acutely ill malnourished infants after discharge from hospital.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Any possibility to breastfeed (carer of reproductive age willing to breastfeed and infant without clinical abnormalities obstructing breastfeeding
Caregivers consent to participation in the study
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Breastfeeding peer support intervention
Other interventionIn addition to support as currently recommended by the World Health Organization (WHO) and National IMAM guidelines, care givers will receive a homebased individualized face to face support provided by breastfeeding peer supporters and phone call support upto 7 weeks post hospital discharge.
Standard Care
Other interventionCaregivers will receive post-discharge support as currently recommended by the World Health Organization (WHO) and national IMAM guidelines.
Treatment groups
Trial outcomes
Primary outcomes
Weight gain
The primary outcome for the trial is growth (weight gain) assessed at 26 weeks of age
Secondary outcomes
Morbidity
Assess morbidity at 39 weeks and 52 weeks of age
Mortality
To assess for mortality at the age of 39 to 52 weeks of age
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: